Go to Pathways list
Support our work
DONATE NOW

The impact of COVID19 on drug development and the future of clinical trials

E-session 530002 / NO CME Add to My Agenda

Instructions to use e-Eso

Expert:

Normand Blais, expert of session 'The impact of COVID19 on drug development and the future of clinical trials'

Normand Blais
CHUM- Hôpital Notre Dame
Montreal, Canada

Expert:

Anastasios Stathis, expert of session 'The impact of COVID19 on drug development and the future of clinical trials'

Anastasios Stathis
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

Expert:

Daniel Heng, expert of session 'The impact of COVID19 on drug development and the future of clinical trials'

Daniel Heng
Tom Baker Cancer Center
Calgary, Canada

Discussant: Ramon De Mello
Federal University of São Paulo (UNIFESP), São Paulo, Brazil


The live session starts in about 12 days

Access to the live session will open 10 minutes before the start of the session





Share on:
Save to my calendar:

This session is part of the following pathway(s):

COVID-19 - Impact in oncology

In order to access to the CME test, please check the minimum system requirements.
If the WebEx platform is used in temporary mode, access to the CME test can not be guaranteed

Check the minimum system requirements

08
Jun 2020
18:15-19:00 CET

The live session starts in about 12 days
Top